Genetic information from myelodysplastic syndromes’ patients incorporated in the latest update of the international standard risk assessment metric: the IPSS-M
In vitro myelopoiesis from iPSCs resembles human early blood formation and opens the door to new therapeutic opportunities for cancer and inflammatory diseases
The Josep Carreras Leukaemia Research Institute, has been selected by the National Cancer Institute for the Cancer Proteome Project with the support of the Spanish Ministry of Science and Innovation
